{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T02:20:10Z","timestamp":1768011610753,"version":"3.49.0"},"reference-count":38,"publisher":"Portland Press Ltd.","issue":"3","license":[{"start":{"date-parts":[[2021,1,26]],"date-time":"2021-01-26T00:00:00Z","timestamp":1611619200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,2,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hemolytic Uremic Syndrome (HUS), a disease triggered by Shiga toxin (Stx), is characterized by hemolytic anemia, thrombocytopenia and renal failure. The inflammatory response mediated by polymorphonuclear neutrophils (PMNs) and monocytes is essential to HUS onset. Still, the role of anti-inflammatory cytokines is less clear. The deficiency of IL-10, an anti-inflammatory cytokine, leads to severe pathology in bacterial infections but also to beneficial effects in models of sterile injury. The aim of this work was to analyze the role of IL-10 during HUS. Control and IL-10 lacking mice (IL-10\u2212\/\u2212) were intravenously injected with Stx type 2 (Stx2) and survival rate was evaluated. PMN and circulating and renal pro- and anti-inflammatory factors were analyzed by FACS and enzyme-linked immunosorbent assay (ELISA) respectively. IL-10\u2212\/\u2212 mice showed a higher survival associated with lower renal damage reflected by reduced plasma urea and creatinine levels than control mice. Circulating PMN increased at 72 h in both mouse strains accompanied by an up-regulation of CD11b in control mice. In parallel, renal PMN were significantly increased only in control mice after toxin. Plasma TNF-\u03b1, IL-6 and corticosterone levels were higher increased in IL-10\u2212\/\u2212 than control mice. Simultaneously renal TNF-\u03b1 raised constantly but was accompanied by increased TGF-\u03b2 levels in IL-10\u2212\/\u2212 mice. These results demonstrate that the profile of circulating and renal cytokines after Stx2 differed between strains suggesting that balance of these factors could participate in renal protection. We conclude that IL-10 absence has a protective role in an experimental model of HUS by reducing PMN recruitment into kidney and renal damage, and increasing mice survival.<\/jats:p>","DOI":"10.1042\/cs20200468","type":"journal-article","created":{"date-parts":[[2021,1,26]],"date-time":"2021-01-26T11:48:48Z","timestamp":1611661728000},"page":"575-588","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Absence of interleukin-10 reduces progression of shiga toxin-induced hemolytic uremic syndrome"],"prefix":"10.1042","volume":"135","author":[{"given":"Gonzalo Ezequiel","family":"Pineda","sequence":"first","affiliation":[{"name":"Laboratorio de Patog\u00e9nesis e Inmunolog\u00eda de los Procesos Infecciosos, Instituto de Medicina Experimental (CONICET)-Academia Nacional de Medicina, Buenos Aires, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00e1rbara","family":"Rearte","sequence":"additional","affiliation":[{"name":"Laboratorio de Fisiolog\u00eda de los Procesos Inflamatorios, Instituto de Medicina Experimental (CONICET)-Academia Nacional de Medicina, Buenos Aires, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Florencia","family":"Todero","sequence":"additional","affiliation":[{"name":"Laboratorio de Fisiolog\u00eda de los Procesos Inflamatorios, Instituto de Medicina Experimental (CONICET)-Academia Nacional de Medicina, Buenos Aires, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea Cecilia","family":"Bruballa","sequence":"additional","affiliation":[{"name":"Laboratorio de Patog\u00e9nesis e Inmunolog\u00eda de los Procesos Infecciosos, Instituto de Medicina Experimental (CONICET)-Academia Nacional de Medicina, Buenos Aires, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan Mauro","family":"Bernal","sequence":"additional","affiliation":[{"name":"Laboratorio de Patog\u00e9nesis e Inmunolog\u00eda de los Procesos Infecciosos, Instituto de Medicina Experimental (CONICET)-Academia Nacional de Medicina, Buenos Aires, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4470-5857","authenticated-orcid":false,"given":"Romina Jimena","family":"Fernandez-Brando","sequence":"additional","affiliation":[{"name":"Laboratorio de Patog\u00e9nesis e Inmunolog\u00eda de los Procesos Infecciosos, Instituto de Medicina Experimental (CONICET)-Academia Nacional de Medicina, Buenos Aires, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin Amadeo","family":"Isturiz","sequence":"additional","affiliation":[{"name":"Laboratorio de Fisiolog\u00eda de los Procesos Inflamatorios, Instituto de Medicina Experimental (CONICET)-Academia Nacional de Medicina, Buenos Aires, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elsa","family":"Zotta","sequence":"additional","affiliation":[{"name":"Laboratorio de Fisiopatogenia, Departamento de Ciencias Fisiol\u00f3gicas, Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catalina Dirney","family":"Alba-Soto","sequence":"additional","affiliation":[{"name":"Instituto de Microbiolog\u00eda y Parasitolog\u00eda M\u00e9dica (IMPaM, CONICET-UBA), Departamento de Microbiolog\u00eda, Facultad de Medicina, Universidad de Buenos Aires (UBA), Buenos Aires, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0533-9516","authenticated-orcid":false,"given":"Marina Sandra","family":"Palermo","sequence":"additional","affiliation":[{"name":"Laboratorio de Patog\u00e9nesis e Inmunolog\u00eda de los Procesos Infecciosos, Instituto de Medicina Experimental (CONICET)-Academia Nacional de Medicina, Buenos Aires, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1670-6262","authenticated-orcid":false,"given":"Mar\u00eda Victoria","family":"Ramos","sequence":"additional","affiliation":[{"name":"Laboratorio de Patog\u00e9nesis e Inmunolog\u00eda de los Procesos Infecciosos, Instituto de Medicina Experimental (CONICET)-Academia Nacional de Medicina, Buenos Aires, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"288","published-online":{"date-parts":[[2021,2,10]]},"reference":[{"key":"2021113011193586600_B1","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/j.injury.2007.09.016","article-title":"The systemic inflammatory response induced by trauma is reflected by multiple phenotypes of blood neutrophils","volume":"38","author":"Pillay","year":"2007","journal-title":"Injury"},{"key":"2021113011193586600_B2","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1097\/00006454-199810000-00010","article-title":"Inflammatory mediators in Escherichia coli O157:H7 hemorrhagic colitis and hemolytic-uremic syndrome","volume":"17","author":"Proulx","year":"1998","journal-title":"Pediatr. Infect. Dis. J."},{"key":"2021113011193586600_B3","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/S0140-6736(05)71144-2","article-title":"Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome","volume":"365","author":"Tarr","year":"2005","journal-title":"Lancet"},{"key":"2021113011193586600_B4","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1097\/01.mop.0000152997.66070.e9","article-title":"Hemolytic uremic syndrome; pathogenesis, treatment, and outcome","volume":"17","author":"Siegler","year":"2005","journal-title":"Curr. Opin. Pediatr."},{"key":"2021113011193586600_B5","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1146\/annurev.immunol.19.1.683","article-title":"Interleukin-10 and the interleukin-10 receptor","volume":"19","author":"Moore","year":"2001","journal-title":"Annu. Rev. Immunol."},{"key":"2021113011193586600_B6","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/nri2711","article-title":"The regulation of IL-10 production by immune cells","volume":"10","author":"Saraiva","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"2021113011193586600_B7","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1574-695X.2012.00931.x","article-title":"Recent insights into microbial triggers of interleukin-10 production in the host and the impact on infectious disease pathogenesis","volume":"64","author":"Duell","year":"2012","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"2021113011193586600_B8","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.1128\/IAI.00047-11","article-title":"Interleukin-10 and immunity against prokaryotic and eukaryotic intracellular pathogens","volume":"79","author":"Cyktor","year":"2011","journal-title":"Infect. Immun."},{"key":"2021113011193586600_B9","doi-asserted-by":"publisher","DOI":"10.1097\/SHK.0000000000001558","article-title":"Involvement of NF-kappaB1 and the non-canonical NF-kappaB signaling pathway in the pathogenesis of acute kidney injury in Shiga-toxin-2-induced hemolytic-uremic syndrome in mice","author":"Sobbe","year":"2020","journal-title":"Shock"},{"key":"2021113011193586600_B10","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/S1473-3099(06)70577-1","article-title":"The two faces of interleukin 10 in human infectious diseases","volume":"6","author":"Mege","year":"2006","journal-title":"Lancet Infect. Dis."},{"key":"2021113011193586600_B11","doi-asserted-by":"publisher","first-page":"91","DOI":"10.5500\/wjt.v3.i4.91","article-title":"Role of IL-10 in the progression of kidney disease","volume":"3","author":"Sinuani","year":"2013","journal-title":"World J. Transplant."},{"key":"2021113011193586600_B12","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.cytogfr.2010.09.002","article-title":"Biology of interleukin-10","volume":"21","author":"Sabat","year":"2010","journal-title":"Cytokine Growth Factor Rev."},{"key":"2021113011193586600_B13","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1016\/j.ajpath.2011.01.001","article-title":"Enhanced liver regeneration in IL-10-deficient mice after partial hepatectomy via stimulating inflammatory response and activating hepatocyte STAT3","volume":"178","author":"Yin","year":"2011","journal-title":"Am. J. Pathol."},{"key":"2021113011193586600_B14","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1097\/SHK.0000000000001233","article-title":"Consequences of the lack of IL-10 in different endotoxin effects and its relationship with glucocorticoids","volume":"52","author":"Cordoba-Moreno","year":"2019","journal-title":"Shock"},{"key":"2021113011193586600_B15","doi-asserted-by":"publisher","first-page":"188","DOI":"10.2353\/ajpath.2007.060370","article-title":"Accelerated wound closure in mice deficient for interleukin-10","volume":"170","author":"Eming","year":"2007","journal-title":"Am. J. Pathol."},{"key":"2021113011193586600_B16","doi-asserted-by":"publisher","first-page":"3971","DOI":"10.1128\/IAI.71.7.3971-3978.2003","article-title":"Development of DNA vaccines against hemolytic-uremic syndrome in a murine model","volume":"71","author":"Capozzo","year":"2003","journal-title":"Infect. Immun."},{"key":"2021113011193586600_B17","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1093\/infdis\/151.5.775","article-title":"The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli","volume":"151","author":"Karmali","year":"1985","journal-title":"J. Infect. Dis."},{"key":"2021113011193586600_B18","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/j.1365-2249.2005.02659.x","article-title":"Endogenous glucocorticoids modulate neutrophil function in a murine model of haemolytic uraemic syndrome","volume":"139","author":"Gomez","year":"2005","journal-title":"Clin. Exp. Immunol."},{"key":"2021113011193586600_B19","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1006\/clim.2000.4862","article-title":"Shiga toxin-2 induces neutrophilia and neutrophil activation in a murine model of hemolytic uremic syndrome","volume":"95","author":"Fernandez","year":"2000","journal-title":"Clin. Immunol."},{"key":"2021113011193586600_B20","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1128\/IAI.00679-08","article-title":"Shiga toxin 2 targets the murine renal collecting duct epithelium","volume":"77","author":"Psotka","year":"2009","journal-title":"Infect. Immun."},{"key":"2021113011193586600_B21","doi-asserted-by":"publisher","first-page":"3689","DOI":"10.1128\/IAI.00616-10","article-title":"Role of tumor necrosis factor alpha in disease using a mouse model of Shiga toxin-mediated renal damage","volume":"78","author":"Lentz","year":"2010","journal-title":"Infect. Immun."},{"key":"2021113011193586600_B22","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1006\/mpat.2002.0501","article-title":"Tumour necrosis factor alpha is not an essential component of verotoxin 1-induced toxicity in mice","volume":"32","author":"Wolski","year":"2002","journal-title":"Microb. Pathog."},{"key":"2021113011193586600_B23","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.clinbiochem.2003.10.001","article-title":"Which is more effective in the prevention of renal ischemia-reperfusion-induced oxidative injury in the early period in mice: interleukin (IL)-10 or anti-IL-12?","volume":"37","author":"Koken","year":"2004","journal-title":"Clin. Biochem."},{"key":"2021113011193586600_B24","doi-asserted-by":"crossref","first-page":"3949","DOI":"10.4049\/jimmunol.143.12.3949","article-title":"Involvement of IL-6 in mesangial proliferative glomerulonephritis","volume":"143","author":"Horii","year":"1989","journal-title":"J. Immunol."},{"key":"2021113011193586600_B25","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/ki.1990.193","article-title":"Interleukin 6 is an autocrine growth factor for mesangial cells","volume":"38","author":"Ruef","year":"1990","journal-title":"Kidney Int."},{"key":"2021113011193586600_B26","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3389\/fimmu.2017.00405","article-title":"Interleukin-6 signaling pathway and its role in kidney disease: an update","volume":"8","author":"Su","year":"2017","journal-title":"Front. Immunol."},{"key":"2021113011193586600_B27","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1006\/taap.1995.1165","article-title":"Cadmium-induced renal damage and proinflammatory cytokines: possible role of IL-6 in tubular epithelial cell regeneration","volume":"134","author":"Kayama","year":"1995","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"2021113011193586600_B28","doi-asserted-by":"publisher","first-page":"F596","DOI":"10.1152\/ajprenal.00365.2015","article-title":"TGF-beta signaling in the kidney: profibrotic and protective effects","volume":"310","author":"Sureshbabu","year":"2016","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"2021113011193586600_B29","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1146\/annurev.immunol.24.021605.090737","article-title":"Transforming growth factor-beta regulation of immune responses","volume":"24","author":"Li","year":"2006","journal-title":"Annu. Rev. Immunol."},{"key":"2021113011193586600_B30","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ccr.2009.06.017","article-title":"Polarization of tumor-associated neutrophil phenotype by TGF-beta: \u201cN1\u201d versus \u201cN2\u201d TAN","volume":"16","author":"Fridlender","year":"2009","journal-title":"Cancer Cell"},{"key":"2021113011193586600_B31","doi-asserted-by":"publisher","first-page":"F1420","DOI":"10.1152\/ajprenal.00263.2019","article-title":"Involvement of high mobility group box 1 in the pathogenesis of severe hemolytic uremic syndrome in a murine model","volume":"317","author":"Maeda","year":"2019","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"2021113011193586600_B32","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1046\/j.1523-1755.1999.00710.x","article-title":"Regulation of mesangial cell proliferation","volume":"56","author":"Schocklmann","year":"1999","journal-title":"Kidney Int."},{"key":"2021113011193586600_B33","doi-asserted-by":"publisher","first-page":"E754","DOI":"10.1152\/ajpendo.00227.2014","article-title":"Alterations in the profile of blood neutrophil membrane receptors caused by in vivo adrenocorticotrophic hormone actions","volume":"307","author":"Machado","year":"2014","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"2021113011193586600_B34","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1189\/jlb.1209793","article-title":"Functional heterogeneity and differential priming of circulating neutrophils in human experimental endotoxemia","volume":"88","author":"Pillay","year":"2010","journal-title":"J. Leukoc. Biol."},{"key":"2021113011193586600_B35","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1182\/blood-2007-07-099648","article-title":"The coordinated action of G-CSF and ELR + CXC chemokines in neutrophil mobilization during acute inflammation","volume":"111","author":"Wengner","year":"2008","journal-title":"Blood"},{"key":"2021113011193586600_B36","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1203\/00006450-199806000-00008","article-title":"Monocyte chemoattractant protein-1 and interleukin-8 levels in urine and serum of patents with hemolytic uremic syndrome","volume":"43","author":"van Setten","year":"1998","journal-title":"Pediatr. Res."},{"key":"2021113011193586600_B37","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.3389\/fimmu.2018.01459","article-title":"Modeling hemolytic-uremic syndrome: in-depth characterization of distinct murine models reflecting different features of human disease","volume":"9","author":"Dennhardt","year":"2018","journal-title":"Front. Immunol."},{"key":"2021113011193586600_B38","doi-asserted-by":"publisher","first-page":"6323","DOI":"10.4049\/jimmunol.166.10.6323","article-title":"IL-10-deficient mice demonstrate multiple organ failure and increased mortality during Escherichia coli peritonitis despite an accelerated bacterial clearance","volume":"166","author":"Sewnath","year":"2001","journal-title":"J. Immunol."}],"container-title":["Clinical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/135\/3\/575\/904008\/cs-2020-0468.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/135\/3\/575\/904008\/cs-2020-0468.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T05:44:34Z","timestamp":1697694274000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/clinsci\/article\/135\/3\/575\/227676\/Absence-of-interleukin-10-reduces-progression-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,2,12]]}},"URL":"https:\/\/doi.org\/10.1042\/cs20200468","relation":{},"ISSN":["0143-5221","1470-8736"],"issn-type":[{"value":"0143-5221","type":"print"},{"value":"1470-8736","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,2]]},"published":{"date-parts":[[2021,2]]}}}